Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.
Br J Clin Pharmacol
; 20(5): 511-3, 1985 Nov.
Article
em En
| MEDLINE
| ID: mdl-3907678
ABSTRACT
Flurbiprofen has been compared with phenylbutazone in a double-blind study involving 33 patients with acute gout. Patients received either flurbiprofen 400 mg daily for 48 h followed by 200 mg daily, or phenylbutazone 800 mg daily for 48 h followed by 400 mg daily. The drugs were of comparable efficacy, while side-effects were uncommon and relatively mild. Flurbiprofen appears to be a satisfactory alternative to phenylbutazone in the management of acute gouty arthritis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Propionatos
/
Fenilbutazona
/
Flurbiprofeno
/
Gota
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
En
Revista:
Br J Clin Pharmacol
Ano de publicação:
1985
Tipo de documento:
Article